Literature DB >> 2450468

Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.

M C Galas1, M F Lignon, M Rodriguez, C Mendre, P Fulcrand, J Laur, J Martinez.   

Abstract

In the present study, hepta- and octapeptide analogues of the C-terminal part of cholecystokinin, modified on the C-terminal phenylalanine residue, were synthesized. CCK analogues were prepared in which the peptide bond between aspartic acid and phenylalanine had or had not been modified and were lacking the C-terminal primary amide function. These CCK derivatives were able to cause full stimulation of amylase release from rat pancreatic acini but without a decrease in amylase release at supramaximal concentrations. There was a close relationship between the abilities of these derivatives to stimulate amylase release and their abilities to inhibit binding of 125I-BH-CCK-9 to CCK receptors on rat and guinea pig pancreatic acini. These CCK analogues were also able to recognize the guinea pig brain CCK receptors, some of them being particularly potent. The findings indicate that the aromatic ring of phenylalanine is important for the binding to brain and pancreatic CCK receptors, whereas the C-terminal primary amide function is not essential for the binding to pancreatic CCK receptors but is crucial for biological activity of rat pancreatic acini.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450468     DOI: 10.1152/ajpgi.1988.254.2.G176

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.

Authors:  C Oiry; J Pannequin; A Cormier; J C Galleyrand; J Martinez
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  The micelle-associated 3D structures of Boc-Y(SO3)-Nle-G-W-Nle-D-2-phenylethylester (JMV-180) and CCK-8(s) share conformational elements of a calculated CCK1 receptor-bound model.

Authors:  Mohanraja Kumar; Joseph R Reeve; Weidong Hu; Laurence J Miller; David A Keire
Journal:  J Med Chem       Date:  2008-06-10       Impact factor: 7.446

Review 3.  Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.

Authors:  L C Rovati
Journal:  Int J Pancreatol       Date:  1991-04

4.  Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion.

Authors:  A K Saluja; M Saluja; H Printz; A Zavertnik; A Sengupta; M L Steer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Cholecystokinin-stimulated enzyme secretion from dispersed rabbit pancreatic acinar cells: phosphorylation-dependent changes in potency and efficacy.

Authors:  P H Willems; S E Van Emst-de Vries; J J De Pont
Journal:  Pflugers Arch       Date:  1995-09       Impact factor: 3.657

6.  Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer.

Authors:  I R Swift; J P Smith
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 7.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

8.  Suppression of Ca2+ oscillations induced by cholecystokinin (CCK) and its analog OPE in rat pancreatic acinar cells by low-level protein kinase C activation without transition of the CCK receptor from a high- to low-affinity state.

Authors:  H Y Gaisano; L J Miller; J K Foskett
Journal:  Pflugers Arch       Date:  1994-07       Impact factor: 3.657

9.  Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor.

Authors:  Géraldine Ibarz; Catherine Oiry; Eric Carnazzi; Philippe Crespy; Chantal Escrieut; Daniel Fourmy; Jean Claude Galleyrand; Didier Gagne; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

10.  Effects of cholecystokinin and carbachol on membrane fluidity in pancreatic acini.

Authors:  Z H Wang; G Ohshio; N Okada; T Imamura; T Tanaka; M Kohmoto; M Yoshida; J Tanaka; S Arii; T Sasaoki; N Funaki; M Imamura
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.